Company profile
SITERA Pharma
SITERA is developing new therapies to tackle neurodegenerative diseases and meet the urgent needs of all patients
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- Montpellier
- Founded
- 2025
- Office locations
- 1
SITERA Pharma company summary
SITERA Pharma is a company in the Biotechnology Research industry, headquartered in Montpellier, founded in 2025. On LinkedIn the company has around 6 employees. Its listed specialties include Biotechnology, Neurodegenerative diseases, Central Nervous System.
What technology does SITERA Pharma use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About SITERA Pharma
SITERA Pharmaceuticals is a preclinical-stage biotech developing small molecule therapeutics that target Mitochondria-Associated Membranes (MAMs), a critical hub for neuronal signaling and metabolism. Our mission: deliver innovative therapies for patients with rare and prevalent neurodegenerative diseases who have run out of options. Leveraging a proprietary platform combining cutting-edge chemistry and biology, we design potent, selective, and safe CNS therapeutics, addressing some of the most challenging unmet needs in neurology.
Specialties
Where is SITERA Pharma located?
SITERA Pharma lists 1 location.
Compare companies similar to SITERA Pharma
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
SITERA Pharma siterapharma.com | Biotechnology Research | 6 | 2025 | Montpellier |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about SITERA Pharma
What does SITERA Pharma do?
SITERA Pharmaceuticals is a preclinical-stage biotech developing small molecule therapeutics that target Mitochondria-Associated Membranes (MAMs), a critical hub for neuronal signaling and metabolism. Our mission: deliver innovative therapies for patients with rare and prevalent neurodegenerative diseases who have run out of options. Leveraging a proprietary platform combining cutting-edge chemistry and biology, we design potent, selective, and safe CNS therapeutics, addressing some of the most challenging unmet needs in neurology.
How many employees does SITERA Pharma have?
SITERA Pharma has around 6 employees on LinkedIn.
Where is SITERA Pharma headquartered?
SITERA Pharma is headquartered in Montpellier.
When was SITERA Pharma founded?
SITERA Pharma was founded in 2025.
Build a lead list from companies like SITERA Pharma
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.